The relationship of CDKN2A and CDKN2B expression with the corresponding SCNA levels seemed to indicate that complex pathways regulated their transcription levels and that their tumor suppressor properties were not evident in ccRCC. The gene discussed is CDKN2B; the disease is neoplasm.